Molecular mechanisms of activation in CDK2

Neva Bešker1, Andrea Amadei, Marco D'Abramo

  • 1a Dipartimento di Scienze e Tecnologie Chimiche , Universita' di Roma "Tor Vergata" , via della Ricerca Scientifica, Rome 1 00185 , Italy .

Insights

Cyclin-dependent kinases (CDKs) undergo conformational changes crucial for cellular functions. This study reveals two key protein regions that sequentially rearrange, enabling transitions between CDK open and closed states efficiently.

Area of Science:

  • Biochemistry and Molecular Biology
  • Computational Biology
  • Structural Biology

Background:

  • Cyclin-dependent kinases (CDKs) are vital enzymes regulating cellular processes.
  • CDK biological activity is intrinsically tied to their conformational flexibility and large-scale rearrangements.
  • Understanding these conformational transitions is key to deciphering CDK function and regulation.

Purpose of the Study:

  • To investigate the conformational transitions between the open and closed states of CDKs.
  • To identify the key protein regions and mechanisms governing these transitions.
  • To demonstrate an efficient computational method for studying macromolecular conformational changes.

Main Methods:

  • Application of an enhanced sampling technique to model CDK conformational changes.
  • Analysis of conformational intermediates to map transition pathways.
  • Computational cost reduction for studying protein dynamics.

Main Results:

  • Identified two critical protein regions that sequentially rearrange during CDK state transitions.
  • Revealed distinct, minor rearrangements specific to each transition pathway.
  • Demonstrated the ability to generate transition pathways at significantly reduced computational expense.

Conclusions:

  • The conformational transition of CDKs is regulated by sequential rearrangements of specific protein regions.
  • The presented enhanced sampling method provides a robust, simple, and computationally inexpensive approach.
  • This methodology is broadly applicable to studying conformational transitions in various macromolecules.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
100.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.4K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

2.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K